News

With PCOS insulin resistance and early diabetes risk Indian women face unique metabolic challenges Here’s what science says ...
While most side effects are likely to disappear when the medication is stopped, any damage to the teeth is permanent ...
As a mass rollout of weight loss injections begins across the NHS, with GPs able to prescribe Mounjaro for the first time ...
Amanda Bynes revealed that she plans to use the injectable drug Ozempic to help achieve her weight loss goals, noting she ...
Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...
It’s about critiquing a world that makes us feel we need these procedures to be worthy of beauty or acceptance in the first ...
About 69,000 new cases and nearly 14,000 deaths are expected this year, according to the American Cancer Society.
Long overlooked in women 40 and older, midlife eating disorders are going up. Eating disorder specialists cite hormonal ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
New research suggests GLP-1 medications like Ozempic and Mounjaro may double the risk of neovascular macular degeneration in diabetic patients, despite benefits for blood sugar control.